Charles Schwab Investment Management Inc Agios Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 457,527 shares of AGIO stock, worth $20.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
457,527
Previous 440,232
3.93%
Holding current value
$20.9 Million
Previous $12.9 Million
53.26%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding AGIO
# of Institutions
226Shares Held
56.3MCall Options Held
275KPut Options Held
251K-
Farallon Capital Management LLC San Francisco, CA5.65MShares$258 Million1.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.5MShares$251 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$222 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.88MShares$177 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.78MShares$127 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.5B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...